CVS HEALTH CORP
CVSNYSE🏆 #108 by market capEarnings Oct 27 · PreUS Equity
$93.50▼ $2.12 (−2.27%)
Market closed · at close1h—
24h▼ 2.3%
7d▼ 5.7%
14d▼ 11.7%
30d▼ 11.7%
1y▲ 42.8%
🏦Market Cap
$119.30B
Mid Cap
📈Revenue Growth (YoY)
+7.4%
Slowing
📊Gross Margin
14.2%
Thin
💵FCF Margin
2.8%
Thin
⚖️P/S Ratio
0.3x
Cheap
Otter Score
62
Fair
📊
Analyst Ratings
Price
$93.50
Total
41
Raised
6
Lowered
3
Avg PT
$117.33
| Institution | Action | Rating | Date |
|---|---|---|---|
UBS | Reiterated | Buy | 2026-07-24 |
Truist Securities | Reiterated | Buy | 2026-07-14 |
Wells Fargo | Reiterated | Overweight | 2026-07-13 |
RBC Capital | Reiterated | Outperform | 2026-07-09 |
Cantor Fitzgerald | Reiterated | Overweight | 2026-07-07 |
B of A Securities | Reiterated | Buy | 2026-06-23 |
Mizuho | Reiterated | Outperform | 2026-06-08 |
Morgan Stanley | Reiterated | Overweight | 2026-06-04 |
Barclays | Reiterated | Overweight | 2026-05-26 |
Bernstein | Reiterated | Outperform | 2026-05-13 |
JP Morgan | Reiterated | Overweight | 2026-05-12 |
TD Cowen | Reiterated | Buy | 2026-05-11 |
Evercore ISI Group | Reiterated | Outperform | 2026-05-07 |
Baird | Reiterated | Outperform | 2026-04-15 |
Piper Sandler | Reiterated | Overweight | 2026-03-31 |
Argus Research | Reiterated | Buy | 2026-01-28 |
Jefferies | Reiterated | Buy | 2025-06-30 |
Leerink Partners | Upgraded | Market Perform → Outperform | 2025-02-13 |
Deutsche Bank | Upgraded | Hold → Buy | 2024-12-03 |
Goldman Sachs | Reiterated | Buy | 2024-05-02 |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2023-09-12 |
Edward Jones | Downgraded | Buy → Hold | 2023-08-18 |
Raymond James | Reiterated | Outperform | 2023-08-04 |
Credit Suisse | Reiterated | Outperform | 2023-05-08 |
Tigress Financial | Reiterated | Buy | 2021-12-23 |
BMO Capital | Reiterated | Market Perform | 2021-05-19 |
Guggenheim | Downgraded | Buy → Neutral | 2021-03-17 |
SVB Leerink | Reiterated | Market Perform | 2020-12-14 |
Citigroup | Reiterated | Buy | 2020-05-07 |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-04-13 |
CFRA | Reiterated | Strong Buy | 2020-02-13 |
Citi | Reiterated | Buy | 2019-11-07 |
Bank of America | Reiterated | Buy | 2019-09-12 |
Oppenheimer | Downgraded | Outperform → Perform | 2019-04-15 |
Leerink Swann | Reiterated | Outperform | 2018-02-09 |
Needham | Upgraded | Hold → Buy | 2017-11-10 |
Loop Capital | Reiterated | Hold | 2017-11-07 |
Cowen & Co. | Reiterated | Outperform | 2015-06-10 |
FBR Capital | Reiterated | Outperform | 2014-11-05 |
ISI Group | Upgraded | Buy → Strong Buy | 2014-01-22 |
Macquarie | Upgraded | Neutral → Outperform | 2012-12-14 |
One row per institution, most recent rating